Nuvasive reported $237.5M in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Atricure ATRC:US USD 122.64M 68.09M
Baxter International BAX:US USD 1.6B 251M
Becton, Dickinson and BDX:US USD 612M 394M
Cardiovascular Systems CSII:US USD 62.85M 3.57M
Cooper Companies COO:US USD 138.2M 108.1M
Dexcom DXCM:US USD 698.1M 37.3M
Edwards Lifesciences EW:US USD 769M 478.8M
Globus Medical GMED:US USD 134.22M 16.55M
Haemonetics HAE:US USD 241.2M 26.25M
Hologic HOLX:US USD 2.44B 101.8M
Inogen INGN:US USD 209.63M 13.99M
Insulet PODD:US USD 553.4M 2.2M
Integra Lifesciences IART:US USD 511.94M 64.78M
Intuitive Surgical ISRG:US USD 6.74B 5.74B
Medtronic MDT:US USD 4.83B 2.69B
Merit Medical Systems MMSI:US USD 51.48M 11.52M
Nuvasive NUVA:US USD 237.5M 11.51M
Orthofix International OFIX:US USD 51.66M 7.88M
Stryker SYK:US USD 1.84B 424M
Tandem Diabetes Care TNDM:US USD 123.79M 8.82M
Teleflex TFX:US USD 397.26M 89.14M
Zimmer Biomet Holdings Inc ZBH:US USD 375.7M 169.7M